Shivom

Shivom Releases Updated Marketplace, Enabling OMX Token Payment via MetaMask

Shivom

Shivom releases ‘Shop 1.5’ which provides consumers with unique incentives and the ability to purchase direct-to-consumer genetic testing products either by OMX token or fiat payment.

London, United Kingdom – May 23, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has released its latest consumer marketplace ‘Shop 1.5’ along with additional updates to the user creation and login. This release will enable consumers with the ability to purchase genetic testings products either by OMX payment or fiat. Additionally, the team has made updates separating the login and creation for enterprise and consumer account and to the health and lifestyle questionnaire within the profile section.

The release will be live to the public at 12:00 pm GMT on 23rd May.  This is a major milestone for Shivom as it will not only enable consumers to purchase directly within Shivom’s marketplace via either OMX token or fiat payment but also bring mainstream partners to Shivom’s innovative blockchain eco-system.

The first group of partners featured on Shop 1.5 include Vitl, Living DNA and Chronomics, which provide ancestry, vitamin and cholesterol and epigenetic testing, respectively. Consumers purchasing any of these kits or services will need to agree to both Shivom and its partners’ terms of use and privacy policies.

At this time, customers are only able to purchase Chronomics epigenetic test with OMX tokens, whilst Living DNA and Vitl’s kits can be purchased with fiat via our partner’s checkout page. This allows users who don’t have tokens to be able to obtain their genetic data file and reports without having to buy tokens from an exchange. Customers who purchase with OMX tokens will receive an automatic email providing a voucher code.  This can then be redeemed on Chronomics website for one month’s subscription of EpiPlanner and a test kit. Please be aware, a minimum subscription of 12 months is required.

All of our D2C partners have undergone a thorough screening from our research and development (R&D) team prior to being granted promotional status within the marketplace. Shivom implements quality control procedures for its marketplace items and criteria which covers a variety of considerations to include data privacy, security and scientific quality (e.g., is a report evidence-based). When products or services are not supported by adequate clinical evidence, Shivom’s R&D team may request further evidence to support the potential partner’s case. Here is the link to our blog which provides an in-depth explanation of the reasoning we have for listing Vitl, Living DNA and Chronomics on our marketplace.

To mark this major milestone, for a limited time only Shivom is offering several exciting promotions. Customers who purchase either LivingDNA or Vitl kits and upload their data on Shivom’s platform will earn OMX tokens and also be eligible to receive special discounts or rewards on select products or services offered by Shivom and its partners (to be separately announced).

Additionally, for a limited time, only customers are also able to purchase Chronomics EpiPlanner Test Kit + 1 Month Subscription for only 1,000 OMX! That’s right, you read that correctly; for ~ $1 USD you can get your hands on this kit. Don’t miss out on this incredible opportunity!

“Today’s Shop 1.5 release stems from the collective hard work, focus and diligent efforts of our tech, science and business teams over the past 12 months. This release provides our early supporters with the ability to earn rewards for participating in our blockchain-based ecosystem and utilize either OMX tokens or fiat to procure top of the line kits from our curated product offerings. Once on our platform, consumers will not only have control over their data and be able to gain considerable health and wellness insights but also have the ability to participate in clinical research and even monetize on personal data if desired. We’re proud of early progress and also look forward to our upcoming MVP release, which will mark another significant milestone and showcase the first cut of our enterprise solution offerings and clinical functionalities.” said Henry Ines, CEO of Shivom.

For more information about Shivom please visit here
To read more about our affiliation with Living DNA please visit here
To read more about our affiliation with Vitl please visit here
To read more about our affiliation with Chronomics please visit here

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Learn more about our direct-to-consumer solutions here

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Telegram: Shivom Announcements
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

Recommended

Vitl

Shivom Adds Vitl to the Marketplace, Offering Customers Vitamin & Cholesterol Blood Tests

Vitl

The VITL Vitamin and Cholesterol Blood Test will provide Shivom’s customers with the ability to track and improve key health markers so you can feel your best more often.

London, United Kingdom – May 14, 2019 – Shivom, a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has teamed up with Vitl who have partnered with experienced doctors, geneticists, biomedical scientists and expert nutritionists from leading organisations around the world, including King’s College London, The Institute for Optimum Nutrition and the European Nutrition Leadership Platform; to offer Vitl’s Vitamin and Cholesterol Blood Test within Shivom’s marketplace. Through this affiliation, Shivom’s customers can track and improve key health markers so you can feel your best more often.

The blood kit which has been developed by Vitl enables consumers via at home simple finger-prick blood test you’ll get a thorough analysis of the key nutrients that have the greatest impact on wellbeing and long-term health. This can be done from the comfort of your own home with no large needles or waiting rooms. The customer will also receive personalised dietary and lifestyle recommendations from a qualified nutritionist, and a bespoke pack of vitamins tailored to your results.

For a limited period of time, Shivom plans to offer unique incentives ranging from token rewards to discounted reports and genetic counselling sessions via Shivom partners and affiliates. “In addition to Living DNA’s ancestry kits, we are now pleased to also offer Vitl’s Vitamin and Cholesterol Blood Test kit, which will provide our customers with deep insights, such as understanding which nutrients are most impactful for well-being and long term health, and the ability to receive customized dietary and lifestyle recommendations from a qualified nutritionist. Customized vitamin supplements will also now be possible to offer our customers based on their personal health and genomic profile. As is the case with all of our curated products, Vitl’s products are world class, grounded in science and are manufactured and processed in accordance with leading international standards and certifications.” Says Henry Ines, CEO of Shivom.

For more information about Shivom please visit here
To read more about our affiliation with Living DNA please visit here

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Learn more about our direct-to-consumer solutions here

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Telegram: Shivom Announcements
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

About Vitl
We understand finding the time to stay healthy is increasingly difficult when you lead a busy, exciting life. So we created VITL to help do the hard work for you. Reinventing the approach to daily nutrition, our products are developed by VITL’s team of leading experts using the highest quality, sustainably sourced ingredients to help you stay healthy and feel great.

Thoughtfully designed to fit effortlessly and conveniently with your busy day, we’re on a mission to make staying healthy a little more achievable.

Love life? #LiveLifeBetter with VITL

For more information about Vitl please visit here

Recommended

Shivom Roadmap_2019

Shivom Roadmap, Release Strategy & Status Update for 2019

Shivom Roadmap_2019

The march of time is relentless and as we start the second quarter of 2019, now is a good time to share some latest updates on Shivom’s roadmap, our evolving blockchain-based genomics & bio datahub and secure-storage and sharing platform, new partnerships and other developments pertaining to the Shivom ecosystem and OMX token.

Our Mission is Unchanged

The Shivom platform involves complex computer science and bioinformatics challenges. We aim to develop novel applications and a next-generation health information exchange and ecosystem which enables direct to consumer (“DTC”), pharma, clinical organizations, enterprises and others to provide customized health insights, therapies & care; and importantly to empower all individuals to own, manage and derive insights from their unique personal biodata in order to better manage their health and wellness. Collectively, we seek to work with all stakeholders to solve the various problems and inefficiencies the industry is facing at this period in time. If successful, our platform and technology solutions will not only lay the foundation for redefining the clinical research and drug discovery landscape but will also empower individuals to proactively manage their health and maintain control over their sensitive healthcare data. Ultimately, Shivom will be instrumental for helping to usher in a new era of precision medicine. Our mission remains unchanged.

MVP Release: Expected Features and Timeline

To deliver our vision, Shivom must hit key milestones and targets. The first key milestone is our MVP, which will demonstrate that data owners can securely store and share health and genomic and other “Omics” data; additionally, initiate an audit trail of data usage and activity based on our dynamic consent and permission features and traceability via the Ethereum blockchain. Enterprise customers such as pharmaceutical and institutional organisations will be able to search datasets based on various parameters, enter into a smart contract with data owners to utilize such data for clinical purposes and be able to run complex bioinformatic pipelines against big data without leaving Shivom’s platform. We remain confident in our abilities as researchers, engineers and operators to deliver on this milestone and key features as expected for our upcoming MVP release.  

We continue to scale up our development team in order to stay on track and reach our MVP milestone, which we plan to release by month-end June 2019. This version of our platform will include full traceability on blockchain, marketplace 2.0, end-to-end data discovery and analysis solution for enterprise customers and more. The requirements we have set include that it must clearly demonstrate traceability via Ethereum blockchain and enterprise customers running complex bioinformatic pipelines against big data without leaving the platform. From launch, the platform must be adaptive and be able to scale. Some features such as blockchain traceability, dynamic consent, updated user creation and login, however, will be offered in an interim release prior to the MVP. This next release will also include an updated marketplace with new products & services offered by our new DTC and telegenetic partners.

New Partners, Affiliates & Customers

Part of our roadmap will include onboarding of select DTC partners to be featured in our marketplace, which caters to consumers who wish to manage and improve their health and wellness within our blockchain- and token-based ecosystem. Our curated products will include select genetic and other testing kits, health reports, telemedicine services and more. For enterprise customers, our clinical platform will feature free and premium pipelines such as GWAS, Plink, Deep Variant and more. Additionally, researchers will have the ability to import their own pipelines from GitHub and in further updates following the MVP will be able to promote them in the marketplace and earn residual income through the use of our OMX tokens.

With these milestones in mind, this month we announced an exciting collaboration with Family Care Path (“FCP”), a spinoff company from world-renowned Cleveland Clinic. FCP maintains a genetic counsellor network and is offers proprietary web-based clinical decision support applications. The pilot for this collaboration will enable Shivom customers to access the FCP MyLegacy application and schedule a virtual genomic counselling session based on genomics and other personal healthcare and family data. We believe this service will be essential and provide much-needed guidance and clarity for our customers and are thrilled to be working with FCP, who are experts and thoughts leaders in the space. To read more about this collaboration visit the press release here.

We also onboarded Living DNA’s 3-in-1 Ancestry kit, which provides consumers with the ability to trace their origins back via maternal ancestors and see how they moved around the world over thousands of years. We are pleased to offer Living DNA as our first ancestry kit given the company’s scientific roots (the company is a collaboration of over 100 world-leading scientists, academic researchers and genetic experts from across the globe) and its relationship with DNA Worldwide Group, described as UK’s most advanced testing platform covering DNA, Drug, Alcohol and Forensic services. The company’s DNA kits are also based on a review of a significantly higher number of DNA markers then comparable lab testing companies; helping to ensure better results. As important, the company maintains strict privacy and security practices, which we require from all of our select partners and customers. To read more about this collaboration visit the press release here.

In addition to other D2C options, we are also working to onboard initial enterprise customers to include academic institutions and pharmaceutical companies. Given the requirements, our project is one of the more complex around the blockchain market today. Our task is difficult, but we are succeeding in our mission and progressing further every day. In parallel, we are also currently developing complementary projects with select partners that haven’t been announced as of yet. It is too early to release many details now but exciting things are happening both with respect to the kind of projects being pursued and the organizations now coalescing around the Shivom ecosystem.  Stay tuned to our Telegram announcements channel for further updates.

Shivom-Branded Products

You may have seen on our website and digital channels we announced our newest addition to our Shivom Innovation Council (“SIC”), Lion Martinez. Lion is a former national and European-level athlete, who has numerous national gold medals (in 100-metre sprint) in his kitty. He was also the youngest-ever Swedish to have participated in the 2002 European Championships in Munich. Lion holds a 100-metre world championship gold medal (2016) and has numerous records and medals (in 60, 100 and 200-metre sprints) to his credit. Additionally, he has been involved in coaching, public speaking and widespread health issues and initiatives over the past 20 years, engaging with children, youth, adults and senior citizens alike.

We are working closely with Lion and other stakeholders to develop an athletics/performance clinical program and other sports-related initiatives to include the development of Shivom-branded athletics products. The sports initiative in cooperation with our partners will use state-of-the-art genomics and analytics to develop insights catered to pro athletes in order to help make them fitter and perform on a higher level.  Our first product “The Complete Athletic Body Systems Report” will provide comprehensive performance related insights derived from multiple biological samples. We aim to unlock the secrets behind what makes an athlete … well, an athlete. We anticipate that our multi-part test will provide deep insights and help the pro user/elite athlete to better understand their body so that they can reach peak performance, reduce the risk of injury and recovery time, and more. Stay tuned for more information on our upcoming pro athletic products.

KuCoin & Exchange Updates

As some of you may be aware, our OMX token has been marked for special treatment on KuCoin for little over a month now. Despite our efforts and progress, trading volume remains low; accordingly, we are unlikely to meet Kucoin’s firm KPI requirement. Taking all factors into consideration to include our latest timelines and the increasingly limited support from the exchange, we have decided to focus our energies and resources on our existing and other prospective exchanges. Accordingly, we plan to pull out of KuCoin Exchange by 15 May 2019. Consequently, it’s imperative that all OMX holders with a balance/account in KuCoin plan accordingly and move their OMX token holdings to another appropriate exchange or secure wallet in a timely manner to avoid any potential complications. We highly recommend that any such individuals take appropriate action and transfer OMX holdings by 06 May 2019. Aside from KuCoin, OMX is currently traded on CoinBene, CoinSuper and IDEX. Our supported wallets include Jaax and Coinomi.


Announcements & Messaging Channels

On April 30th, we announced going live on Blockfolio Signals and Delta Direct. Our Director of Marketing and CEO will be providing updates on the project and token via these portfolio management applications along with our Telegram announcements channel. You may have well noticed we are in the process of moving away from our Telegram supergroup and pushing our active audience to our announcements channels, which will enable better, more targeted communications and excludes the numerous bots associated with the current supergroup. With this in mind and based on feedback received to date, we plan to phase out our supergroup in the coming months and ask our community members to join our new announcement channels in order to continue to get the latest project and token updates. We will give proper notice to our subscribers well in advance to ensure continuity of communications.

Looking Ahead

The next few months will be very exciting for the project. In addition to our scheduled MVP release, we have many other news and announcements to share as we continue to execute and focus on developing our applications & solutions and building the Shivom ecosystem. We look forward to keeping you updated on all and advancing the mission. As always, the entire Shivom team would like to thank everyone for their interest in the project, patience and continued belief in our team, technology and vision. We are also grateful for our early partners and their support and commitment to the project. As always, onwards and upwards!

About Shivom
Shivom is a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed. By utilising innovative technologies such as blockchain and machine-learning algorithms, we are able to democratise genomics.

Our mission is to bring exponential value to our end-users within the genomics industry. We believe that the unique combination of our in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratisation of genomics and healthcare data.

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Telegram: Shivom Announcements
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

Recommended

Our Alpha Public Release!

Back in August, we announced that we would be releasing a platform in order for our community to test and give us feedback on the first iteration of our Alpha product.

After onboarding a wealth of new talent and welcoming Henry Ines to the role of CEO, we felt it time to take a step back and reassess our current position. We realized that many of our competitors, both startups in the blockchain space and traditional genetics companies had spent a significant amount of time streamlining their UI/UX and USPs. It became clear to us that we needed to innovate in an area that’s often overlooked – secure storage. In perfecting such a solution, we would be able to offer our community and competitors alike greater freedom and transparency where the storage and sharing of their DNA data is concerned, having a positive knock-on effect on the direct-to-consumer genetic testing industry.

Months of development later, after several scrum meetings and all-nighters, we’re thrilled to unveil to the community the long-awaited Alpha Release!


A Sleek UI/UX Brand Overhaul

Users will also notice that we’ve greatly simplified our sign-up process, stripping it down to three easy steps:

Select whether you’re a consumer or an enterprise user, before adding general account information (name, DOB, country, etc.)

Complete health and wellness information by answering a range of questions (which, in later releases, will not only help us better assess which products we should provide our audience with, but also improve the search function for organizations seeking particular DNA datasets). Of course, the user will be able to specify whether they wish to be ‘discoverable’ in our Enterprise Search feature.

The final step in the sign-up process is adjusting user permissions – you’ll be able to set search, viewing and contact permissions that are linked to DNA data uploaded onto the platform. We’ve implemented toggle functionality to offer users a more granular experience over categories. For instance, they may choose to only make their data searchable and available to academic research teams over governmental organizations.

DNA Upload & Encryption

As aforementioned, we’ve spent countless hours fine-tuning our secure storage feature whilst ensuring newcomers and users of previous genetic testing kits are provided with a seamless experience for securely uploading their data. If you’ve used another testing service previously, all you need is your genetic information to get started – usually, this is stored in a file with a .vcf extension.

Navigate to the MYDNA page and click on ‘Upload’ to select the requisite file from your device. Once selected, it will be encrypted and subsequently stored on the Shivom platform. In successive releases, expect an even simpler process, where logins for sites like 23andMe or Ancestry can be used in order to directly import data.

Additionally, this page allows you to pre-order home testing kits. Select this option to be added to the pre-order list for the kits, which will be shipped in Q1 of 2019.

 

What’s Next?

Shivom will continue iterating on its product and fleshing out our core features – above all, our work is driven with a focus on security and accessibility. In tandem, we’ll launch numerous upgrades to campaign management for enterprise users and our Enterprise Search function (providing granular filters for organizations seeking out specific data sets, i.e. those from specific regions, associated with certain diseases or conditions, etc.).

For users that wish to share their data with researchers or institutes in the medical field (all whilst being remunerated for their participation), we’ll be rolling out the ability to anonymously provide organizations with datasets within a set timeframe, leveraging blockchain-based payments directly into an integrated wallet accessible via Shivom’s web portal.

Stay tuned for more exciting updates on our roadmap, developments and partnerships in the coming weeks. Go ahead and experiment with the Alpha, and be sure to let us know what you like, what could be improved, and what you’d like to see added in the future via the Intercom feature at the bottom right-hand side of the portal.

Until next time,

The Shivom Team

Recommended